{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T13:40:02Z","timestamp":1750945202734,"version":"3.41.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":109,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intestinalfailurejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Intestinal Failure"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intf.2025.100058","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T17:38:09Z","timestamp":1747417089000},"page":"100058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Conversion from SMOFlipid\u00ae to Omegaven\u00ae as a salvage therapy for intestinal failure associated liver disease"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2022-4840","authenticated-orcid":false,"given":"Stella","family":"Sabbatini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Belza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda","family":"Courtney-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Gattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8072-5727","authenticated-orcid":false,"given":"Yaron","family":"Avitzur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intf.2025.100058_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jpen.2232","article-title":"ASPEN definitions in pediatric intestinal failure","volume":"46","author":"Modi","year":"2022","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jpen.1537","article-title":"Essential fatty acid requirements and intravenous lipid emulsions","volume":"43","author":"Gramlich","year":"2019","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib3","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1177\/0148607115595978","article-title":"Phytosterols, lipid administration, and liver disease during parenteral nutrition","volume":"39","author":"Zaloga","year":"2015","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/SLA.0b013e3181b36657","article-title":"Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury","volume":"250","author":"Puder","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.intf.2025.100058_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MPG.0b013e318182c8f6","article-title":"Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome","volume":"48","author":"Diamond","year":"2009","journal-title":"J Pedia Gastroenterol Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jpeds.2012.10.019","article-title":"High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy","volume":"162","author":"Premkumar","year":"2013","journal-title":"J Pedia"},{"key":"10.1016\/j.intf.2025.100058_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1941406413513461","article-title":"Use of fish oil\u2013based lipid emulsions in infants with intestinal failure\u2013associated liver disease: a case series","volume":"6","author":"St-Jules","year":"2014","journal-title":"ICAN Infant Child Adolesc Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib8","article-title":"Intravenous fish oil and pediatric intestinal failure\u2013associated liver disease: changes in plasma phytosterols, cytokines, and bile acids and erythrocyte fatty acids","author":"Calkins","year":"2017","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/INF.0000000000001187","article-title":"High prevalence of antimicrobial-resistant gram-negative colonization in hospitalized cambodian infants","volume":"35","author":"Turner","year":"2016","journal-title":"Pedia Infect Dis J"},{"key":"10.1016\/j.intf.2025.100058_bib10","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpeds.2013.10.066","article-title":"Bedside to bench: the risk of bleeding with parenteral omega-3 lipid emulsion therapy","volume":"164","author":"Dicken","year":"2014","journal-title":"J Pedia"},{"unstructured":"Omegaven Prescribing Information, Fresenius Kabi USA, LLC. 2018. n.d.","key":"10.1016\/j.intf.2025.100058_bib11"},{"key":"10.1016\/j.intf.2025.100058_bib12","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ncp.10778","article-title":"ASPEN lipid injectable emulsion safety recommendations part 2: neonate and pediatric considerations","volume":"36","author":"Cober","year":"2021","journal-title":"Nutr Clin Pr"},{"key":"10.1016\/j.intf.2025.100058_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/a-2212-6874","article-title":"and the International Intestinal Failure Registry. The Development of the International Intestinal Failure Registry and an Overview of its Results","volume":"34","author":"Avitzur","year":"2024","journal-title":"Eur J Pedia Surg"},{"key":"10.1016\/j.intf.2025.100058_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0148607110363614","article-title":"A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition","volume":"34","author":"Goulet","year":"2010","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib15","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/0148607115626921","article-title":"Preventing the progression of intestinal failure\u2013associated liver disease in infants using a composite lipid emulsion: a pilot randomized controlled trial of SMOFlipid","volume":"41","author":"Diamond","year":"2017","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jpen.1692","article-title":"An observational study of smoflipid vs intralipid on the evolution of intestinal failure\u2013associated liver disease in infants with intestinal failure","volume":"44","author":"Belza","year":"2020","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib17","first-page":"258","article-title":"Liver function in pediatric recipients: a comparison of intralipid and smoflipid","volume":"26","author":"Daniel","year":"2021","journal-title":"J Pedia Pharm Ther"},{"key":"10.1016\/j.intf.2025.100058_bib18","first-page":"5","article-title":"Predicting basal metabolic rate, new standards and review of previous work","volume":"39 1","author":"Schofield","year":"1985","journal-title":"Hum Nutr Clin Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/0148607113495416","article-title":"Pediatric intestinal failure\u2013associated liver disease is reversed with 6 months of intravenous fish oil","volume":"38","author":"Calkins","year":"2014","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clnesp.2022.03.036","article-title":"The impact of a lipid injectable emulsion (SMOF) on conjugated bilirubin levels in children receiving prolonged parenteral nutrition: A large single center experience","volume":"49","author":"Navaratnarajah","year":"2022","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.intf.2025.100058_bib21","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/jpen.2413","article-title":"Current practices in lipid emulsion utilization in the prevention and treatment of intestinal failure\u2013associated liver disease: a survey of pediatric intestinal rehabilitation and transplant centers","volume":"46","author":"Raghu","year":"2022","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/0148607114567200","article-title":"Reversal of intestinal failure\u2013associated liver disease by switching from a combination lipid emulsion containing fish oil to fish oil monotherapy","volume":"40","author":"Lee","year":"2016","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib23","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.3390\/jcm9113393","article-title":"Fish oil monotherapy for intestinal failure-associated liver disease on SMOFlipid in the neonatal intensive care unit","volume":"9","author":"Lee","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.intf.2025.100058_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/jpen.1823","article-title":"Reversal of intestinal failure\u2013associated liver disease by increasing fish oil in a multi-oil intravenous lipid emulsion in adult short bowel\u2013syndrome patients","volume":"45","author":"Park","year":"2021","journal-title":"J Parent Enter Nutr"},{"key":"10.1016\/j.intf.2025.100058_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3945\/ajcn.116.137083","article-title":"Predictors of failure of fish-oil therapy for intestinal failure\u2013associated liver disease in children","volume":"104","author":"Nandivada","year":"2016","journal-title":"Am J Clin Nutr"}],"container-title":["Intestinal Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950456225000235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950456225000235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:59:25Z","timestamp":1750942765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950456225000235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":25,"alternative-id":["S2950456225000235"],"URL":"https:\/\/doi.org\/10.1016\/j.intf.2025.100058","relation":{},"ISSN":["2950-4562"],"issn-type":[{"type":"print","value":"2950-4562"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conversion from SMOFlipid\u00ae to Omegaven\u00ae as a salvage therapy for intestinal failure associated liver disease","name":"articletitle","label":"Article Title"},{"value":"Intestinal Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intf.2025.100058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Intestinal Rehabilitation & Transplant Association.","name":"copyright","label":"Copyright"}],"article-number":"100058"}}